SolvaySOLB
SOLB logo
Fair Value
€25.1
Share price11 Jun
€26.184.3% overvalued intrinsic discount
Loading
1Y-9.60%
7D-1.13%

SOLB: Recent Macroeconomic Pressures Will Shape Outlook Amid Stable Fundamentals

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
25 Dec 24
Updated
11 Jun 26
Views
347
Not Invested

Last Update 11 Jun 26

Fair value Increased 0.63%

SOLB: Rare Earth Supply Plans And Mixed Ratings Will Shape Fair Value Outlook

Narrative Update

The analyst price target for Solvay is now set at €25.10. This move is supported by recent Street research, where analysts highlight the company’s rare earth capabilities and adjust targets in a €26 to €30 range, while fine tuning assumptions around discount rates, modest revenue declines, profit margins and future P/E expectations.

Analyst Commentary

Recent Street research around Solvay clusters around its rare earth exposure, updated price targets and differing views on how much value the company can realistically deliver to shareholders from here.

Bullish Takeaways

  • Bullish analysts see Solvay’s rare earth capabilities as a key asset that can support shareholder value creation. This view is reflected in an upgrade from a more cautious stance to a neutral one.
  • The stock still carries at least one positive rating at a large international bank, with a price target of €30. This sits above the current €25.10 blended target and is cited as a sign of confidence in the longer term earnings and P/E potential.
  • A recent upward adjustment of a price target to €26 suggests that some analysts now view the risk reward profile as more balanced after earlier caution, rather than seeing substantial downside from current levels.
  • The focus on fine tuning assumptions instead of wholesale changes to models points to a view among bullish analysts that Solvay’s core investment case remains intact, even as estimates are refined.

Bearish Takeaways

  • Bearish analysts have trimmed price targets, including a reduction to €30 from €32 at JPMorgan and a €4 cut at another large broker. This indicates reduced headroom versus previous expectations.
  • The move to a Hold stance rather than a clear Buy indicates that some see limited upside at current levels, especially once rare earth potential and current valuation are already factored into their models.
  • Target cuts are linked to more cautious assumptions on revenue and margins. This suggests concern that execution risks or softer end markets could pressure earnings relative to earlier forecasts.
  • The overall shift in targets within a relatively tight €26 to €30 band highlights that analysts see Solvay more as a stock that needs to prove its value creation plans through delivery, rather than one priced for strong growth.

What's in the News

  • Solvay and Viridis Mining and Minerals signed a non binding Letter of Intent to source mixed rare earth carbonate from Brazil for Solvay's La Rochelle facility in France, aiming to support critical materials supply for advanced technologies. Source: company announcement, 1 Jan 2026.
  • The proposed collaboration is intended to strengthen resilience and diversification of rare earth supply chains into Europe, directly tying into Solvay's rare earth positioning that analysts have been focusing on. Source: company announcement, 1 Jan 2026.
  • The partners plan to reach a final investment decision in the second half of 2026, with commercial production targeted by 2028, which sets a clear timeline for when this supply arrangement could become operational. Source: company announcement, 1 Jan 2026.
  • The Letter of Intent underlines Solvay's ambition to scale up rare earth production and reinforce its role as a supplier to the European rare earth market, an area that is central to current analyst debates around long term value for shareholders. Source: company announcement, 1 Jan 2026.

Valuation Changes

  • Fair Value: €25.10, up slightly from €24.94, reflecting a modest uplift in the modelled central value for the stock.
  • Discount Rate: 7.99%, down slightly from 8.07%, which marginally increases the present value of projected cash flows.
  • Revenue Growth: projected revenue decline of 2.38%, compared with a prior decline of 2.27%, signalling a slightly more cautious view on top line trends in € terms.
  • Net Profit Margin: 5.54%, edging down from 5.60%, pointing to a small reduction in expected profitability on each € of revenue.
  • Future P/E: 13.73x, up from 13.49x, indicating a modestly higher multiple being applied to future earnings expectations.
3 viewsusers have viewed this narrative update

Key Takeaways

  • Expansion in rare earths and battery materials, alongside operational digitalization, positions Solvay for stronger asset utilization, margin gains, and long-term growth leadership.
  • Sustainability initiatives and supply chain localization strategies align with regulatory trends and premium pricing opportunities, further supporting future-proofing and profitability.
  • Prolonged pricing pressures, trade tensions, operational inefficiencies, and environmental liabilities threaten Solvay's revenue stability, margin strength, and future growth opportunities.

Catalysts

About Solvay
    Provides basic and performance chemicals worldwide.
What are the underlying business or industry changes driving this perspective?
  • Growing customer demand for rare earth production capacity outside of China-triggered by Chinese export controls and seeking greater supply chain localization-positions Solvay's La Rochelle plant for potential rapid expansion, paving the way for incremental high-value revenue streams and improved asset utilization in the coming years.
  • Advancement of digitalization initiatives (IoT, drones, process automation) is delivering consistent structural cost savings across Solvay's plants, which are expected to exceed interim targets and drive higher operating margins and earnings over the medium term.
  • Solvay's strategic focus on energy transition and sustainability (including reducing greenhouse gas emissions by 10% year-on-year and ongoing investments in green chemistry) is enabling the company to future-proof its portfolio, align with regulatory shifts, and benefit from premium pricing, positively impacting long-term margins and growth.
  • Ramp-up of new, highly competitive soda ash and rare earth capacities offers scope for improved profitability and share gains once market demand normalizes or supply rationalization (e.g., Chinese plant closures) occurs; this operational leverage may be underappreciated in the current valuation.
  • Increased customer interest and potential policy support for European battery materials and rare earths, driven by electrification and EV sector growth, creates an opportunity for Solvay to become a leading regional supplier, supporting sustained top-line growth and margin expansion over the long term.
Solvay Earnings and Revenue Growth

Solvay Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Solvay's revenue will decrease by 2.4% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -0.5% today to 5.5% in 3 years time.
  • Analysts expect earnings to reach €239.3 million (and earnings per share of €2.2) by about June 2029, up from -€25.0 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as €443.3 million.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 13.8x on those 2029 earnings, up from -109.7x today. This future PE is greater than the current PE for the GB Chemicals industry at 13.2x.
  • Analysts expect the number of shares outstanding to grow by 0.09% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.99%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Prolonged pricing pressure and decreased demand in key segments, particularly soda ash and Coatis, driven by high Chinese inventories, aggressive Asian competition, and global overcapacity, threaten to depress group revenues and net margins into 2026 and potentially beyond.
  • Heightened global trade tensions-especially tariffs between the U.S., Brazil, China, and the EU-are fueling demand uncertainty, destabilizing order volumes, and could structurally alter export flows, risking further revenue volatility and a long-term earnings drag.
  • Operational inefficiencies due to persistent industry underutilization (e.g., running plants below optimal utilization rates) are inflating cost per unit and weakening Solvay's EBITDA margins, with no clear indication of short-term market recovery to support a margin rebound.
  • Legacy and ongoing environmental liabilities, including high annual cash outflows for environmental remediation and litigation, are pressuring free cash flow and may require higher-than-expected provisions, potentially constraining capital for future strategic growth.
  • Delayed or uncertain expansion in strategic growth areas (e.g., rare earths) due to strict cash management, dependence on customer commitments, and unfavorable market conditions could limit Solvay's ability to capture long-term revenue opportunities, affecting its future earnings growth trajectory.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of €25.1 for Solvay based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €32.0, and the most bearish reporting a price target of just €18.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €4.3 billion, earnings will come to €239.3 million, and it would be trading on a PE ratio of 13.8x, assuming you use a discount rate of 8.0%.
  • Given the current share price of €26.22, the analyst price target of €25.1 is 4.5% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Solvay?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

€25.1
vs €26.184.3% overvalued intrinsic discount
PastFuture-2b14b2015201820212024202620272029Revenue €4.3bEarnings €239.3m
-2.4%
Revenue growth
5.5%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Solvay

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Undervalued with reasonable growth potential.

Market cap€2.7b
PB2.5x
Estimated Growth-1.9%
Dividend Yield9.3%
Full analysis

CEO & management

Philippe Kehren
CEO
3.5yrs
CEO Tenure

Provides basic and performance chemicals worldwide.